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Abstract 
Objective: To determine the prevalence and the severity of wheezing in the first year of 
life for infants who live in Santo André, São Paulo, Brazil.
Methods: Cross sectional study with the administration of the Estudio Internacional de 
Sibilancias en Lactantes (EISL), which is a standardized and validated written questionnaire 
applied to parents and/or guardians of infants aged 12-24 months treated at primary 
health units, vaccination centers, day care centers, or kindergartens. The questionnaire 
consisted of questions regarding demographic characteristics, presence of wheezing, 
respiratory infections, and risk factors. Results were analyzed using the SPSS for Windows, 
20.0 (SPSS Inc. – Chicago, Il, United States). Logistic regression was applied to verify 
variables associated to recurrent wheezing.
Results: Among the 1,028 infants studied, 48.5% had one or more episodes of wheezing 
during the first 12 months of life (wheezing once), and 23.9% had three or more episodes 
(recurrent wheezing). Nocturnal symptoms, severe breathing difficulty, and visits to the 
emergency room were observed in 67.3%, 42.4%, and 60.7% of infants, respectively. Among 
the studied infants, 19.4% were hospitalized, and 11.0% had a medical diagnosis of asthma 
in the first year of life. Use of β2-agonists, inhaled corticosteroids, oral corticosteroids, and 
leukotriene receptor antagonists were observed in 88.8%, 21.0%, 54.9%, and 3.2% of children 
with wheezing, respectively. Use of oral corticosteroids, perception of breathlessness by 
parents, diagnosis of asthma, pneumonia, and hospitalization for pneumonia were more 
frequent among infants with recurrent wheezing (p<0.001).
Conclusions: In the city of Santo André, approximately half of infants had at least one 
episode of wheezing in the first year of life, and almost 25% had recurrent wheezing. 
Wheezing disorders in Santo André have early onset and high morbidity. 
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda.  
All rights reserved.
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Resumo
Objetivo: Verificar a prevalência e a gravidade da sibilância no primeiro ano de vida em 
lactentes no município de Santo André. 
Métodos: Estudo transversal com aplicação de questionário escrito, padronizado e vali-
dado do estudo EISL (do espanhol: Estudio Internacional de Sibilancias en Lactantes) aos 
pais e/ou responsáveis por lactentes de 12 a 24 meses de idade, em unidades básicas de 
saúde, durante campanhas de vacinação em creches e escolas maternais. O questionário 
consiste de questões sobre características demográficas, presença de sibilância, infec-
ções respiratórias e fatores de risco. Os dados obtidos foram analisados com o Statistical 
Package for the Social Sciences for Windows, versão 20.0 (SPSS inc., Chicago, Il, EUA). A 
regressão logística foi aplicada para analisar as variáveis associadas à presença de sibilos 
recorrentes.
Resultados: Do total de 1.028 lactentes estudados, 48,5% apresentaram um ou mais 
episódios de sibilância nos primeiros 12 meses de vida (sibilância alguma vez) e 23,9%, 
três ou mais episódios (sibilância recorrente). Sintomas noturnos, dificuldade intensa 
para respirar e visitas à emergência estiveram presentes em 67,3%, 42,4% e 60,7% dos 
lactentes, respectivamente, sendo que 19,4% foram hospitalizados e 11,0% tiveram diag-
nóstico médico de asma. O uso de β2–agonistas, corticoides inalatórios, corticoides orais 
e antagonistas do receptor de leucotrienos foram observados em 88,8%, 21,0%, 54,9% e 
3,2% das crianças com sibilância, respectivamente. Uso de corticoide oral, percepção de 
falta de ar pelos pais, diagnóstico de asma, pneumonia e hospitalização por pneumonia 
foram mais frequentes entre os sibilantes recorrentes (p<0,001). 
Conclusões: No município de Santo André, cerca da metade dos lactentes estudados 
apresentava pelo menos um episódio de sibilância no primeiro ano de vida, e metade 
deles apresentou sibilância recorrente, com início precoce e alta morbidade.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos 
os direitos reservados.
Introduction
Allergic disorders are one of the major health problems of 
modern societies; among them, asthma is the most com-
mon chronic disease of childhood,1 and is associated with 
high rates of hospitalization, visits to emergency servic-
es, and significant morbidity, responsible for considerable 
impact on public health systems.2
Asthma is an inflammatory disease that increases air-
way response to certain stimuli and reversible bronchial 
obstruction with or without treatment, characterized by 
symptoms such as recurrent wheezing, dyspnea, and cough. 
In children younger than 5 years, it may be confused with 
other diseases.3 
Wheezing is a common clinical finding in children, espe-
cially in the first years of life. Epidemiological studies have 
shown a high prevalence of wheezing in this age group. 
Studies in developed countries have shown prevalence 
between 20% and 30%, with high recurrence of episodes.4,5 
In developing countries, prevalence rates appear to be 
higher. In a cohort in Chile, 188 newborns were followed for 
up to one year of age, and wheezing episodes were identi-
fied in 80%, whereas recurrence was observed in 50%.6 
Recently, the European and American Academies of 
Asthma, Allergy, and Immunology published a consensus on 
wheezing in infants describing four distinct wheezing pat-
terns during childhood, as well as its evolution.3 They are: 
transient wheezing (wheezing during the first three years of 
life and discontinuation after this age); non-atopic wheez-
ing (wheezing triggered mainly by viruses that tends to dis-
appear with age); persistent asthma (wheezing associated 
with clinical manifestations of atopy, eosinophilia, and/or 
increased total serum levels of IgE or proven sensitization 
to food and/or aeroallergens, or having a father and/or 
mother with asthma); and severe intermittent wheezing 
(occasional acute wheezing episodes associated with few 
symptoms besides acute conditions and with the presence 
of atopy characteristics).3
The International Study of Asthma and Allergies in 
Childhood (ISAAC) protocol proposed a unique method of 
research and allowed for maximizing the significance of 
epidemiological research on asthma and other allergic dis-
eases in childhood, as well as supporting international col-
laboration.7
In Brazil, a cross-sectional study conducted in São Paulo 
found a prevalence of recent wheezing (one or more epi-
sodes in the past 12 months) of 11% among children aged 
6-11 months, and 14.3% among those aged 12-23 months.7 
In the same city, a cohort of children at high risk for devel-
oping asthma showed that, after 30 months of follow up, 
52% of these patients had recurrent wheezing.8
The Estudio Internacional de Sibilâncias en Lactentes 
(EISL), an international multicenter study, was created to 
compare the prevalence of wheezing in infants with the 
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participation of Latin American countries (Brazil, Chile, 
Colombia, Mexico, and Venezuela), the Netherlands, and 
Spain in its first phase. As in the ISAAC study, a written 
questionnaire (WQ) was prepared and validated in each 
participating country in order to obtain reliable data on 
wheezing in infants.9,10 The standardized EISL WQ con-
sists of 45 questions about demographic characteristics, 
wheezing and other respiratory symptoms, use of medica-
tions, medical diagnostics, and potential risk factors, to be 
answered by the infant’s parents or guardians.11 
The municipality of Santo André is located in the metro-
politan region of São Paulo, which includes a group of munic-
ipalities known as Great ABC. It has a population of 673,396 
inhabitants (2009 estimate), and occupies an area of 175 
km², resulting in a demographic density of 3,816.52 inhab-
itants/km².12 The climate is subtropical, humid mesother-
mal and, according to the climate classification of Köppen-
geiger, Cfb type (warm, humid summers, and mild winters). 
The mean annual temperature is around 19 ºC.12 The region’s 
economy is mainly represented by the industrial sector. In 
this context, this study aimed to describe and evaluate the 
prevalence and severity of wheezing in infants in the city, 
using the EISL standardized questionnaire validated for the 
Portuguese language, as there are other studies conducted 
in several Brazilian municipalities.
Methods
This was a cross-sectional study performed between 2006-
2010 in the city of Santo André. Parents or guardians of 
1,028 infants from different social classes, who lived in the 
municipality, were interviewed and answered the WQ. To 
perform the study, the EISL coordinators determined that 
the sample should include at least 1,000 infants. The sam-
ple size was based on the International Study of Asthma and 
Allergies in Childhood (ISAAC), considering a prevalence of 
wheezing of 30% and 25% in two different centers, with a 
95% power and a significance level of 1% for this sample, to 
ensure proper comparisons between the centers and coun-
tries, even for questions with a low prevalence of positive 
answers.11 
Children whose parents reported chronic diseases that 
had an effect on the respiratory system (neuropathies, 
myopathies, heart diseases, genetic disorders, and severe 
malformations), as well as those whose questionnaire com-
pletion was below 90%, were excluded. 
The questionnaire, originally in Spanish, was previously 
translated into Brazilian Portuguese and validated.13,14 The 
chosen age range was 12 to 24 months, due to the difficulty 
in completing the study with infants up to 15 months, and 
considering the previous validation for the extended range 
up to 36 months.10 
The interviews were conducted in ten basic health units 
(approximately half of the city’s network) during three 
vaccination campaigns in four public daycare centers 
and four private centers. Before applying the WQ, par-
ents or guardians were informed of the study objectives, 
and those who agreed to participate signed the informed 
consent. Subsequently, they were interviewed by trained 
researchers. 
The WQ-EISL contains 45 questions about demographic 
characteristics, wheezing, respiratory diseases, pneumo-
nia, and personal and family history, as well as other risk 
factors.11 In addition, there are questions regarding the use 
of inhaled medications for relief of symptoms and their 
frequency, medical diagnosis of asthma, age of onset and 
frequency of upper airway infections, presence of lower 
airway infections, individual or family presence of atopy, 
duration of breastfeeding, immunization, and exclusive 
breastfeeding time.11 It also contains data on identifica-
tion, anthropometric measures, environmental conditions, 
whether the child attended day care and initial age of 
attendance, presence of pets, environmental pollution, 
number of siblings, educational level, and ethnicity.15
The wheezing infants were separated by gender, number 
of wheezing episodes, and asthma diagnosis. Those who had 
at least one episode of wheezing were evaluated according 
to gender regarding the frequency of wheezing, presence 
of symptoms, use of medications and diagnosis of asthma, 
pneumonia and airway infections, and type of treatment.
The results obtained were transferred to a database, 
developed in Microsoft Excel 2000 and analyzed using SPSS 
for Windows, release 20.0 (SPSS Inc. – Chicago, Illinois, 
USA). Parametric (Student’s t-test) and nonparametric tests 
(chi-squared and Fisher’s exact tests) and logistic regres-
sion (backward stepwise) were used for variable analysis. 
The p values <0.05 were considered statistically significant 
to reject the null hypothesis. 
The study was approved by the Research Ethics Committee 
of the Faculdade de Medicina do ABC (protocol CEP/FMABC 
No. 108/205). 
Results
Of the 1,038 initial questionnaires, there were inconsisten-
cies in ten, and 1,028 were considered valid. The female 
parent or guardian answered 846 (82.2%) questionnaires, 
whereas in 530 cases (51.5%) the responder was male, with 
no significant difference between the genders. 
Episodes of wheezing in the first 12 months of life 
occurred in 499 (48.5%) infants (at least once); 253 infants 
(24.6%) had one or two episodes (occasional wheezing) and 
246 (23.9%), three or more episodes (recurrent wheezing). 
Infants that had at least one wheezing episode were 
divided by gender and shown in Table 1. Males showed 
higher values than females for weight and height at birth, 
as well as at 12 months of life. Table 2 presents the demo-
graphic and clinical characteristics of the groups of wheez-
ing infants with one to two episodes (occasional wheezing) 
and three or more episodes (recurrent wheezing). Three or 
more wheezing episodes were observed in the first year of 
life in 499 (48.5%) infants.
There was a significant association between recurrent 
wheezing and weight during the interview, age at wheezing 
onset, use of oral and inhaled corticosteroids, perception 
of breathlessness by parents, hospitalization for wheez-
ing, asthma diagnosis, occurrence of pneumonia, and hos-
pitalization for pneumonia. In the multivariate analysis, 
however, the authors observed independent associations of 
recurrent wheezing only with the use of oral corticosteroids 
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(OR=1.8, 95%CI: 1.1-2.8, p=0.009) and asthma diagnosis 
(OR=2.7, 95%CI 1.2-6.0, p=0 .012). 
The parents of 55 (5.3%) infants reported a medical 
diagnosis of asthma, and the vast majority had recurrent 
wheezing (74.5%).
Table 3 shows the characteristics of infants with and 
without a medical diagnosis of asthma. In the multivariate 
analysis, there was an association between asthma diag-
nosis and use of oral corticosteroids (OR=4.1, 95%CI: 1.7-
9.8, p=0.001), occurrence of pneumonia (OR=2.8, 95%CI: 
1.4-5.5, p=0.002), and having family members with asthma 
(OR=2.1, 95%CI: 1.1-4.1, p=0.02).
Discussion
To date, there has been no previous study on the preva-
lence of wheezing in the first year of life in infants resid-
ing in the municipality of Santo André. In Brazil, the EISL 
questionnaire has been administered to children aged 12 to 
15 months in the cities of Belém, Belo Horizonte, Curitiba, 
Fortaleza, Porto Alegre, Recife, and São Paulo.13,16 Some 
authors, however, noting the difficulty in diagnosing asth-
ma in children aged up to 3 years, as well as aiming to dif-
ferentiate wheezing caused by other disorders in this age 
group, performed the validation of the WQ-EISL in children 
aged 12 to 36 months. The objectives of this validation 
were also to verify whether the results obtained in a more 
restricted age range persisted in older children, in addition 
to recording its reproducibility and internal consistency.17. 
Therefore, during the course of this research, it was con-
sidered appropriate to extend the age range of question-
naire application from 12-15 months to 12-24 months. 
In the city of Curitiba, state of Paraná, Brazil, the preva-
lence of at least one wheezing episode in the first year of 
life was 45.4%, and in São Paulo, 46.0%,13,18 much lower 
results than those found in Porto Alegre (63.3%),14 possi-
bly due to climatic conditions. In Santo André, this study 
demonstrated that 48.5% of the infants had wheezing in 
the first year of life, similar to what was observed in São 
Table 1    Clinical characteristics of infants that had at 
least one wheezing episode, separated according to gender, 
expressed in numbers (%)
Male
(n=273)
Female
(n=226)
general
(n=499)
pa
≥1 episode of 
wheezing
144 (52.7) 102 (45.1) 246 (49.3) 0.090
Use of inhaled 
B2-receptor 
agonist
239 (87.5) 204 (90.2) 443 (88.8) 0.438
Use of inhaled 
corticoid 
65 (24.0) 40(17.7) 105 (21.0) 0.086
Use of anti-
leukotriene 
agents
10 (3.7) 06 (2.6) 16 (3.2) 0.450
Use of oral 
corticoids
157 (57.5) 117 (51.7) 274 (54.9) 0.047
Nocturnal 
awakenings 
sometimes
191 (70.0) 145 (64.1) 336 (67.3) 0.169
Visits to 
emergency 
service
166 (61.0) 137 (60.6) 303 (60.7) 0.966
Perception of 
breathlessness 
by parents
114 (41.7) 98 (43.3) 212 (42.4) 0.718
Hospitalization 
for bronchitis
55 (20.1) 42 (18.5) 97 (19.4) 0.661
Asthma diagnosis 29 (10.6) 26 (11.6) 55 (11.0) 0.754
Pneumonia 75 (27.4) 65 (28.8) 140 (28.0) 0.750
Hospitalization 
for pneumonia
38 (14.0) 27 (12.0) 65 (13.0) 0.515
a Chi-squared test
Table 2    Demographic and clinical characteristics of 
infants according to the number of wheezing episodes in 
the first year of life (n=499)
1 to 2 
episodes/year
(n=253)
≥3 episodes/
year
(n=246)
pa
Male gender [n (%)] 129 (51.0) 144 (58.5) 0.090
Birth weight (kg) 3.091±51 3.187±543 0.049
Current weight 
(kg – mean ± SD)
10.664±1706 11.297±1852 <0.0001
Birth length  
(cm – mean ± SD)
47.6±3.0 48.4±3.0 0.006
Current height  
(cm – mean ± SD)
78.0±7.0 78.8±7.4 0.195
Age at wheezing 
onset (months – 
mean ± SD)
6.5±3.2 4.7±2.8 <0.0001
Black/mixed 
ethnicity [n (%)]
91 (36.0) 69 (28.0) 0.058
Use of inhaled 
B2-agonist [n (%)]
217 (85.7) 226 (91.8) 0.012
Use of inhaled 
corticosteroids  
[n (%)]
39 (15.4) 66 (26.8) 0.002
Use of anti-
leukotriene [n (%)]
08 (3.1) 08 (3.2) 0.835
Use of oral 
corticoids [n (%)]
115 (45.4) 159 (64.6) <0.0001
Nocturnal 
awakenings 
sometimes [n (%)]
157 (62.0) 179 (72.7) 0.011
Visits to emergency 
service [n (%)]
146 (57.7) 157 (63.8) 0.162
Perception of 
breathlessness by 
parents [n (%)]
85 (33.5) 127 (51.6) <0.0001
Hospitalization for 
wheezing [n (%)]
37 (14.6) 60 (24.3) 0.006
Asthma diagnosis  
[n (%)]
14 (5.5) 41 (16.7) <0.0001
Pneumonia [n (%)] 55 (21.8) 85 (34.5) <0.0001
Hospitalization for 
pneumonia [n (%)]
18 (7.1) 47 (19.1) <0.0001
a Student’s t-test or chi-squared test.
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Paulo and Curitiba, which are areas with high prevalence 
of wheezing and asthma in children and adolescents.15,19 A 
cross-sectional study conducted in São Paulo found a preva-
lence of recent wheezing (one or more episodes in the past 
12 months) of 11% in children aged 6-11 months and of 
14.3% between 12-23 months.20
Several studies have shown a higher frequency of recur-
rent wheezing in developing countries when compared 
to developed countries.6,21,22 In São Paulo, in a cohort of 
infants from low-income families, it was shown that, after 
30 months of follow up, 52% had recurrent wheezing.8 Muiño 
et al. followed a cohort of newborns up to 12 years of age in 
the city of Pelotas, state of Rio grande do Sul, Brazil, and 
observed prevalence of transient wheezing (wheezing up 
to 4 years and absence of wheezing at 10-12 years) 43.9%; 
persistent wheezing (wheezing during the entire follow-
up) of 6.4%, and late-onset wheezing (wheezing at 10-12 
years) of 3.3%.23 The present study observed that 23.9% of 
the infants had recurrent wheezing, with three or more 
wheezing episodes in the first years of life, similar to the 
data observed in Curitiba (23%) and lower than in São Paulo 
(27%) and Recife (26%) using the WQ-EISL.12,18,24 
Male gender is known risk factor for wheezing in infancy 
due to the smaller airway diameter.4 In the present study, 
among the wheezing infants, a trend for a higher number 
of males compared to females was observed (273/226), 
but a significant difference was only observed regarding 
the use of oral corticosteroids, which may be due to the 
greater severity of episodes in males. There was no differ-
ence between genders regarding the prevalence of recur-
rent wheezing, use of other medications, and nocturnal 
awakening symptoms, as well as asthma diagnosis.
Recurrent wheezers started having episodes at an ear-
lier age than occasional wheezers and had higher weight at 
the time of the survey, a factor reported by some authors 
as associated with recurrent wheezing and asthma in child-
hood.20 In a prospective study by Martinez et al., most chil-
dren who had wheezing episodes started having them in the 
first year of life. Of these, 50% persisted with symptoms up 
to six years of age, considered asthmatics.4
In the present study, according to information provided 
by the parents, 54.9% of the wheezing infants had used oral 
corticosteroids for the treatment of a wheezing episode, 
with this use being associated with greater frequency and 
severity of episodes. The use of corticosteroids was higher in 
the recurrent wheezing group, when compared to the occa-
sional wheezing group, both by oral (64.6% versus 45.4%) and 
inhaled administration (26.8% versus 15.4%). As expected, 
infants with recurrent wheezing who have a higher risk of 
developing asthma25,26 showed association with variables 
that indicate greater severity of episodes, such as asthma 
diagnosis, pneumonia, and hospitalization for pneumonia. 
Wheezing was identified as a risk factor for pneumonia 
in a study conducted in São Paulo.18 Hospitalization for 
pneumonia, in addition to increasing healthcare system 
costs, results in social and psychological costs, nutritional 
impairment, and risk of opportunistic nosocomial infec-
tions.27 According to the Brazilian Ministry of Health, in 
2006, 34.5% of hospital admissions of individuals younger 
than 1 year of age throughout Brazil were caused by respi-
ratory diseases. In São Paulo, this rate was 34.9% and in 
Santo André, 40%.28
The infants who received a diagnosis of asthma had three 
or more episodes of wheezing, nocturnal symptoms and 
more frequent perception of breathlessness by parents, 
greater use of oral corticosteroids, association with pneu-
monia, and hospitalization for pneumonia. Similar results 
were observed in São Paulo, Maceio, and Curitiba.12,18,24
The present study showed significant associations 
between asthma diagnosis and a greater number of crises, 
perception of breathlessness by the parents, and oral cor-
ticosteroid use. After excluding wheezing caused by viral 
agents, asthma is the most common cause of wheezing in 
childhood.29 However, it was observed that only 5.5% of chil-
dren received this diagnosis. Attaining a correct diagnosis 
of asthma in childhood from the first year of life is impor-
tant for infants with recurrent wheezing.12 Pediatricians, 
when treating a child with recurrent wheezing, often hesi-
tate to use the term “asthma”, tending to emphasize the 
diagnosis of infections. The term “bronchitis” is closer to 
this concept and is usually more easily accepted by par-
ents, as it does not mean, from their point of view, the 
stigma of a chronic and incurable disease. The under- 
diagnosis and undertreatment of asthma are responsible for 
many pediatric hospitalizations.
The delay in the diagnosis of asthma in children results in 
the worsening of symptoms and increased treatment costs.30
Research on wheezing and asthma in childhood are 
required to assist with the implementation of public health 
policies aimed at decreasing socioeconomic and education-
al inequalities among the population and, hence, reduce 
Table 3    Personal and clinical characteristics of infants 
with and without a medical diagnosis of asthma, expressed 
as n (%)
Wheezing 
diagnosed 
(n=55)
No wheezing 
diagnosed 
(n=444)
pa
Male gender 29 (52.7) 244 (55.0) 0.754
Use of inhaled 
B2-agonist 
52 (94.5) 391 (88.0) 0.195
Use of inhaled 
corticosteroid
17 (31.0) 88 (20.0) 0.072
Use of anti-
leukotriene
03 (6.0) 13 (3.0) 0.406
Use of oral 
corticosteroid
42 (76.3)** 232 (52.2) <0.0001
Pneumonia 28 (51.0)** 112 (25.2) <0.0001
Hospitalization for 
pneumonia
16 (29.0)** 49 (11.0) <0.0001
Three or more 
episodes of wheezing
41 (74.5)** 205 (46.2) <0.0001
Nocturnal symptoms 44 (80.0)** 292 (65.8) 0.034
Visits to the ER 40 (72.7) 263 (59.2) 0.053
Perception of 
breathlessness by 
parents
36 (65.5)** 176 (39.6) <0.0001
Hospitalization for 
wheezing
16 (29.0)** 49 (11.0) 0.001
aChi-squared test.
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the prevalence and severity of wheezing in the first year 
of life, especially in developing countries.31 The imple-
mentation of campaigns against passive smoking should be 
encouraged, considering that exposure to cigarette smoke 
in the pre- and/or postnatal period is one of the major risk 
factors for wheezing in infants.32 The study of a cohort of 
children in germany33 showed that having one smoker par-
ent, associated with family history of asthma, increased 
the risk of wheezing by threefold when compared to family 
history of asthma alone. 
It is concluded that in the city of Santo André, half of 
the infants assessed had at least one episode of wheezing 
in the first year of life. Half of these infants are recurrent 
wheezers, and this recurrent condition is associated with 
high morbidity. However, few infants received a diagnosis 
of asthma.
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